Following an RFP dated 8 March 2016 and ultimately a Sole Supply arrangement dated 7 July 2016, TOLMAR AUSTRALIA has decided to discontinue Eligard in New Zealand.

Click here to read the notification from TOLMAR.

Please note that all variants will be delisted from the Pharmaceutical Schedule 1 June 2017

About The Author